Oncolytics Biotech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -98 | -98 | ||
EBITDA | -9,794 | -7,920 | -7,822 | |
EBIT | -9,899 | -7,920 | ||
Net Income | -8,017 | -9,543 | -7,256 | -7,256 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,852 | -4,864 | -6 | -6 |
Cash | 15,942 | 19,598 | 24,850 | 22,295 |
Basic Shares | 77,074 | 76,090 | 76,090 | 76,090 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -403 | -392 | -452 | |
EBITDA | -33,710 | -26,831 | -25,664 | |
EBIT | -33,791 | -27,223 | -26,116 | |
Net Income | -31,710 | -27,752 | -24,835 | -26,304 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,205 | -28,456 | -23,410 | -22,719 |
Cash | 15,942 | 34,912 | 11,666 | 41,262 |
Basic Shares | 77,074 | 67,624 | 58,029 | 53,513 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.10 |
2024-09-30 | -$0.09 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.09 |
